Recombinant CD40L (Ruplizumab Biosimilar) anticorps
Aperçu rapide pour Recombinant CD40L (Ruplizumab Biosimilar) anticorps (ABIN7093061)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Fonction
- Anti-CD40L (ruplizumab biosimilar) mAb
-
Attributs du produit
- BG-9588, hu5c8
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- ELISA 1:5000-10000, Flow Cyt 1:100
-
Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Date de péremption
- 12 months
-
-
- CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))
-
Autre désignation
- CD40L (Ruplizumab Biosimilar)
-
Classe de substances
- Biosimilar
-
Sujet
- Synonyms: CD40LG,CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39
-
ID gène
- 959
-
UniProt
- P29965
Antigène
-